Stereotactic Body Radiation Therapy (SBRT) for lung metastases

References

• Suit H, Skates S, Taghian A, Okunieff P, Efird JT. Clinical implications of heterogeneity of tumor response to radiation therapy. Radiother Oncol 1992; 25: 251–60
   PubMed Web of Science ®Google Scholar
• DeVita VT, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology5^th ed. Lippincott, Philadelphia 1997; 2523–2606
   Google Scholar
• O'Dell WG, Schell MC, Reynolds D, Okunieff P. Dose broadening due to target position variability during fractionated breath-held radiation therapy. Am Assoc Phys Med 2002; 29: 1430–7
   Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 205–16
   PubMed Web of Science ®Google Scholar
• Common Terminology Criteria for Adverse Events version 3.0 (CTCAE v 3.0), Cancer Therapy Evaluation Program 2003. Available at: http://ctep.cancer.gov/reporting/ctc.html.
   Google Scholar
• Blomgren H, Lax I, Göranson H, Kræpelien T, Nilsson B, et al. Radiosurgery for tumors in the body. Clinical experience using a new method. J Radiosurg 1998; 1: 63–74
   Google Scholar
• Uematsu M, Shioda A, Tahara K, Fukui T, Fuyumi Y, Tsumatori G, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients. Cancer 1998; 82: 1062–70
   PubMed Web of Science ®Google Scholar
• Wulf J, Hädinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M. Stereotactic radiotherapy of targets in lung and liver. Strahlenther Onkol 2001; 177: 645–55
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Aoki Y, Tago M, Terahara A, Ohtomo K. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: Original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys 2000; 48: 449–57
   PubMed Web of Science ®Google Scholar
• Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 2001; 51: 666–70
   PubMed Web of Science ®Google Scholar
• Nagata Y, Negoro Y, Aoki T, Mizowaki T, Takayama K, Kokubo M, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002; 52: 1041–6
   PubMed Web of Science ®Google Scholar
• Hara R, Itami J, Kondo T, Aruga T, Abe Y, Ito M, et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 2002; 63: 159–63
   PubMedGoogle Scholar
• Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003; 56: 126–35
   PubMed Web of Science ®Google Scholar
• Hof H, Herfarth KK, Münter M, Hoess A, Motsch J, Wannenmacher M, et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2003; 56: 335–41
   PubMed Web of Science ®Google Scholar
• Lee S, Choi EK, Park HJ, Ahn SD, Kim JH, Kim KJ, et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 2003; 40: 309–15
   PubMed Web of Science ®Google Scholar
• Timmerman RD, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, et al. Extracranial stereotactic radioablation: Result of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003; 124: 1946–55
   PubMed Web of Science ®Google Scholar
• Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004; 60: 186–96
   PubMed Web of Science ®Google Scholar
• Okunieff P, Morgan D, Suit H. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys 1995; 32: 1227–37
   PubMed Web of Science ®Google Scholar
• Timmerman RD, Choy H, Galvin JM, Michalski J, Fowler J, Johnstone D, et al. A phase II trial of Stereotactic Body Radiation Therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer, RTOG 0236,2004. RTOG protocol available online (PDF) www.rtog.org/members/protocols/0236/0236
   Google Scholar
• Varlotto JM, Flickinger JC, Niranjan A, Bhatnager A, Kondziolka D, Lundsford L. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005; 62: 1125–32
   PubMed Web of Science ®Google Scholar
• Suit HD, Howes AE, Hunter N. Dependence of response of a C3H mammary carcinoma to fractionated irradiation on fractionation number and intertreatment interval. Radiat Res 1977; 72: 440–54
   PubMed Web of Science ®Google Scholar
• Hall EJ, Brenner DJ. The radiobiology of radiosurgery: Rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys 1993; 25: 381–5
   PubMed Web of Science ®Google Scholar
• Li WL, Yu JM, Liu GH, Zhong WX, Li WW, Zhang BJ. A comparative study on radiology and pathology target volume in non-small lung cancer. Zhonghua Zhong Liu Za Zhi 2003; 25: 566–8
   PubMedGoogle Scholar
• Yin F-F, Das S, Kirkpatrick J, Oldham M, Wang Z, Zhou S. Physics and imaging for targeting of oligometastases. Semin Radiat Oncol 2006; 16: 85–101
   PubMedGoogle Scholar
• Bradley J, Graham K, Winter J, Purdy J, Komaki R, Roa W, et al. Acute and late toxicity results of RTOG 9311: A dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer. Proc Am Soc Thera Rad Oncol (ASTRO). Int J Radiat Oncol Biol Phys 2003; 57: 137
   Google Scholar